SVB Leerink Comments on Pediatrix Medical Group, Inc.’s Q2 2022 Earnings (NYSE:MD)

Pediatrix Medical Group, Inc. (NYSE:MDGet Rating) – Equities research analysts at SVB Leerink reduced their Q2 2022 earnings estimates for shares of Pediatrix Medical Group in a report released on Tuesday, August 2nd. SVB Leerink analyst W. Mayo now forecasts that the company will post earnings of $0.42 per share for the quarter, down from their previous forecast of $0.45. The consensus estimate for Pediatrix Medical Group’s current full-year earnings is $1.74 per share. SVB Leerink also issued estimates for Pediatrix Medical Group’s FY2022 earnings at $1.70 EPS, FY2023 earnings at $1.73 EPS, FY2024 earnings at $1.78 EPS, FY2025 earnings at $1.91 EPS and FY2026 earnings at $1.94 EPS.

A number of other equities research analysts have also recently issued reports on the stock. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Pediatrix Medical Group from $24.00 to $16.00 in a report on Tuesday, May 10th. StockNews.com cut shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating in a report on Monday, May 2nd. Mizuho dropped their target price on shares of Pediatrix Medical Group from $28.00 to $23.00 in a report on Monday, May 2nd. Finally, TheStreet cut shares of Pediatrix Medical Group from a “b-” rating to a “c+” rating in a report on Wednesday, April 13th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $26.50.

Pediatrix Medical Group Stock Down 13.5 %

Shares of MD stock opened at $19.36 on Thursday. The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.63 and a current ratio of 1.63. The firm’s 50-day moving average is $21.27 and its 200-day moving average is $22.17. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 18.09, a PEG ratio of 1.40 and a beta of 1.84. Pediatrix Medical Group has a 52-week low of $17.17 and a 52-week high of $35.67.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in shares of Pediatrix Medical Group by 2.3% during the 1st quarter. Vanguard Group Inc. now owns 9,541,964 shares of the company’s stock worth $224,045,000 after purchasing an additional 212,150 shares in the last quarter. Alliancebernstein L.P. grew its position in shares of Pediatrix Medical Group by 11.9% during the 4th quarter. Alliancebernstein L.P. now owns 7,359,083 shares of the company’s stock worth $200,241,000 after purchasing an additional 781,646 shares in the last quarter. Lazard Asset Management LLC grew its position in shares of Pediatrix Medical Group by 24.3% during the 1st quarter. Lazard Asset Management LLC now owns 3,263,699 shares of the company’s stock worth $76,631,000 after purchasing an additional 637,798 shares in the last quarter. State Street Corp grew its position in shares of Pediatrix Medical Group by 1.8% during the 4th quarter. State Street Corp now owns 3,211,149 shares of the company’s stock worth $87,375,000 after purchasing an additional 57,309 shares in the last quarter. Finally, River Road Asset Management LLC grew its position in shares of Pediatrix Medical Group by 98.3% during the 1st quarter. River Road Asset Management LLC now owns 2,607,218 shares of the company’s stock worth $61,217,000 after purchasing an additional 1,292,605 shares in the last quarter. Institutional investors and hedge funds own 95.68% of the company’s stock.

Pediatrix Medical Group Company Profile

(Get Rating)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

See Also

Earnings History and Estimates for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.